WisdomTree BioRevolution Fund Rating $14.32 +1.05 (+7.95%) Closing price 07/11/2025 03:38 PM EasternExtended Trading$14.32 0.00 (-0.01%) As of 07/11/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsBuy This Stock WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy 2.68Holdings in WDNA have an aggregate rating of Moderate Buy based on 642 analyst ratings issued in the past year covering 46 companies (72.2% of the portfolio).WDNA Aggregate Price Target$14.32High Prediction$14.32Average Prediction$14.32Low Prediction$14.32Holdings in WDNA have an aggregate price target of $14.32 and a range of $14.32 to $14.32 covering 46 companies (72.2% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy27 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 46 WDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.49%VERVVerve Therapeutics$11.03-0.3%3.0606 of 5 stars2.33$14.57 32.1%92.71%NTRANatera$160.43-1.8%1.6524 of 5 stars3.00$184.63 15.1%15Positive News2.47%NTLAIntellia Therapeutics$11.53-5.2%4.3519 of 5 stars2.65$33.37 189.4%202.36%CRSPCRISPR Therapeutics$56.80-3.7%3.2427 of 5 stars2.53$71.75 26.3%17News CoverageAnalyst ForecastOptions Volume2.19%LLYEli Lilly and Company$793.34+0.3%4.9812 of 5 stars2.75$1,012.56 27.6%20Trending NewsAnalyst ForecastAnalyst Revision2.14%TWSTTwist Bioscience$38.03-1.1%4.3885 of 5 stars2.70$50.40 32.5%10Gap Down2.12%DNAGinkgo Bioworks$9.98-7.5%0.7876 of 5 stars2.00$8.50 -14.8%2News CoverageGap Down2.04%AGIOAgios Pharmaceuticals$39.05-1.2%4.354 of 5 stars2.71$58.60 50.1%7Insider TradeAnalyst Revision1.89%RGNXREGENXBIO$8.68-4.2%4.0454 of 5 stars2.83$31.63 264.3%6News Coverage1.85%GILDGilead Sciences$109.64-4.3%4.9347 of 5 stars2.77$111.38 1.6%26Positive NewsAnalyst Revision1.76%SANASana Biotechnology$4.18+3.0%3.1334 of 5 stars3.00$9.17 119.3%71.74%BNTXBioNTech$112.89-0.9%1.6374 of 5 stars2.83$137.91 22.2%18News CoverageAnalyst Forecast1.74%BEAMBeam Therapeutics$21.16-3.9%2.0931 of 5 stars3.00$48.75 130.4%15News Coverage1.69%VRTXVertex Pharmaceuticals$468.85-2.2%4.3239 of 5 stars2.54$511.62 9.1%28Positive NewsAnalyst Revision1.68%VCYTVeracyte$27.08-1.6%3.5949 of 5 stars2.70$40.90 51.0%101.67%TXG10x Genomics$12.80+1.4%4.5129 of 5 stars2.46$14.13 10.4%131.63%UTHRUnited Therapeutics$295.52-1.5%4.9887 of 5 stars2.69$383.08 29.6%13News CoveragePositive NewsAnalyst Forecast1.60%EDITEditas Medicine$2.88-5.9%4.2503 of 5 stars2.31$4.70 63.2%13Positive News1.60%ARCTArcturus Therapeutics$13.78-4.8%1.7387 of 5 stars3.11$54.00 291.9%9Gap Down1.59%MRNAModerna$33.64-1.9%4.3037 of 5 stars2.04$46.61 38.6%23Trending News1.55%TEMTempus AI$56.88-4.6%2.2898 of 5 stars2.50$65.09 14.4%12Trending NewsInsider Trade1.53%AMGNAmgen$295.27-1.7%4.4373 of 5 stars2.35$307.82 4.2%23Positive NewsAnalyst Revision1.51%CTVACorteva$73.50-1.8%4.2448 of 5 stars2.80$75.54 2.8%15Positive NewsAnalyst Forecast1.32%GPCRStructure Therapeutics$19.01+0.6%2.6114 of 5 stars3.00$76.17 300.7%71.31%DARDarling Ingredients$37.51-2.0%4.42 of 5 stars3.00$46.14 23.0%8Positive News1.30%IONSIonis Pharmaceuticals$41.73-1.5%4.6042 of 5 stars2.78$58.25 39.6%18Positive News1.30%AZNAstraZeneca$71.13-0.9%3.7594 of 5 stars2.83$89.00 25.1%6Positive NewsAnalyst Forecast1.23%TECHBio-Techne$54.14-0.5%4.8898 of 5 stars2.50$70.00 29.3%12News CoverageAnalyst Forecast1.22%RAREUltragenyx Pharmaceutical$29.51-4.9%3.9557 of 5 stars2.93$85.36 189.2%14Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume1.20%STOKStoke Therapeutics$11.86-1.5%4.1439 of 5 stars3.33$24.75 108.7%6Trending News1.19%BMRNBioMarin Pharmaceutical$58.10-1.2%4.9453 of 5 stars2.75$93.61 61.1%24News CoveragePositive News1.16%JNJJohnson & Johnson$156.87-0.5%4.8126 of 5 stars2.55$171.00 9.0%20Trending NewsUpcoming EarningsAnalyst Forecast1.14%DHRDanaher$204.80-0.3%4.8942 of 5 stars2.85$248.43 21.3%20Positive NewsAnalyst Forecast1.13%QUREuniQure$14.40-3.2%2.5667 of 5 stars2.91$37.82 162.6%111.13%BMYBristol Myers Squibb$46.91-3.3%4.8897 of 5 stars2.32$57.69 23.0%22Trending NewsAnalyst ForecastAnalyst Revision1.10%ZTSZoetis$154.91-2.4%4.9242 of 5 stars3.00$212.13 36.9%10Positive News1.06%FOLDAmicus Therapeutics$6.09-3.3%4.1348 of 5 stars2.70$16.22 166.4%10News CoverageAnalyst Revision1.04%ABSIAbsci$2.67-2.2%2.1979 of 5 stars3.00$8.40 214.6%51.04%EXASExact Sciences$51.91-2.6%4.7669 of 5 stars2.95$70.50 35.8%22News CoverageAnalyst Forecast1.03%GERNGeron$1.32-4.3%3.3575 of 5 stars2.60$4.61 249.3%10News CoverageAnalyst ForecastGap Down1.03%GMABGenmab A/S$21.40-2.1%4.0955 of 5 stars2.67$37.80 76.6%12Positive NewsAnalyst Forecast0.98%PFEPfizer$25.65-0.5%4.9708 of 5 stars2.45$28.55 11.3%22Trending NewsAnalyst Revision0.97%RGENRepligen$130.19-2.8%4.6023 of 5 stars2.69$170.75 31.2%13Positive NewsAnalyst Forecast0.96%IMNMImmunome$8.64-3.5%2.095 of 5 stars3.00$23.33 170.1%6Positive News0.94%SWTXSpringWorks Therapeutics$46.991.5735 of 5 stars2.13$52.57 11.9%80.90%REGNRegeneron Pharmaceuticals$567.74+1.4%4.8312 of 5 stars2.80$814.57 43.5%25Trending NewsAnalyst ForecastAnalyst Revision This page (BATS:WDNA) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WDNA Stock Alerts